Mumbai
India
179
2026-01-15
141
2024-10-08
These are the the leading inventors for applications assigned to CIPLA LIMITED:
CIPLA LIMITED based in Mumbai, IN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Solid State Forms of Ensifentrine
#2 | 2023-06-15 ✅ Patent 12,109,270 granted on 2024-10-08Rifaximin complexes
#3 | 2023-04-20 ✅ Patent 12,109,200 granted on 2024-10-08Rifaximin
#4 | 2021-11-25 ✅ Patent 11,267,798 granted on 2022-03-08Process for the preparation of piperine
#5 | 2021-11-11 ✅ Patent 12,036,358 granted on 2024-07-16Single blister-strip based dispenser
#6 | 2021-11-11 ✅ Patent 12,558,321 granted on 2026-02-24Pharmaceutical Formulation
#7 | 2021-10-07 ✅ Patent 12,472,190 granted on 2025-11-18Pharmaceutical Compositions
#8 | 2021-07-01 ✅ Patent 11,931,362 granted on 2024-03-19Stable pharmaceutical formulations of pemetrexed
#9 | 2021-05-27 ✅ Patent 11,596,597 granted on 2023-03-07Depot formulation
#10 | 2021-03-04 ✅ Patent 12,213,798 granted on 2025-02-04Adherence-tracking and monitoring device for metered-dose inhaler
#11 | 2021-02-11 ✅ Patent 11,612,612 granted on 2023-03-28Pharmaceutical compositions
#12 | 2020-11-26RIFAXIMIN
#13 | 2020-05-21 ✅ Patent 10,966,982 granted on 2021-04-06Stable pharmaceutical formulations of pemetrexed
#14 | 2020-05-14RIFAXIMIN COMPLEXES
#15 | 2020-04-30 ✅ Patent 11,390,637 granted on 2022-07-19Salts of antiviral phosphonate analogues and process for preparation thereof
#16 | 2020-04-16 ✅ Patent 12,090,163 granted on 2024-09-17Pharmaceutical compositions
#17 | 2020-02-13 ✅ Patent 11,129,836 granted on 2021-09-28PAR-4 agonists for the treatment of cancer
#18 | 2020-02-13 ✅ Patent 11,234,981 granted on 2022-02-01Combination therapy for use in treating retroviral infections
#19 | 2019-11-21 ✅ Patent 10,912,734 granted on 2021-02-09Depot formulation
#20 | 2019-09-19 ✅ Patent 10,987,305 granted on 2021-04-27Preparation of respirable zafirlukast particles
#21 | 2019-08-15 ✅ Patent 11,207,319 granted on 2021-12-28Method for the treatment of bladder cancer
#22 | 2019-06-06 ✅ Patent 10,709,715 granted on 2020-07-14Method of treating hypertension
#23 | 2019-03-14 ✅ Patent 11,478,483 granted on 2022-10-25Method of treating hypertension
#24 | 2019-01-17 ✅ Patent 10,857,113 granted on 2020-12-08Bezafibrate for the treatment of cancer
#25 | 2019-01-10 ✅ Patent 10,493,079 granted on 2019-12-03Stable carfilzomib formulations
#26 | 2018-12-20 ✅ Patent 10,940,274 granted on 2021-03-09Nasal spray assembly
#27 | 2018-12-06 ✅ Patent 10,765,644 granted on 2020-09-08Methods for the treatment of hepatitis C
#28 | 2018-10-11 ✅ Patent 10,328,153 granted on 2019-06-25Rifaximin complexes
#29 | 2018-09-06 ✅ Patent 10,420,727 granted on 2019-09-24Pharmaceutical antiretroviral composition
#30 | 2018-08-23 ✅ Patent 10,287,248 granted on 2019-05-14Process for the preparation of apremilast
#31 | 2018-08-23 ✅ Patent 10,702,505 granted on 2020-07-07Rifaximin
#32 | 2018-07-12 ✅ Patent 10,471,048 granted on 2019-11-12Thienopyridine derivative for the treatment of hepatitis C infections
#33 | 2018-06-07 ✅ Patent 10,307,432 granted on 2019-06-04Stabilized liquid fosaprepitant formulations
#34 | 2018-05-03 ✅ Patent 10,098,890 granted on 2018-10-16Stable carfilzomib formulations
#35 | 2018-04-26 ✅ Patent 10,301,282 granted on 2019-05-28Polymorphic form X of nilotinib dihydrochloride hydrate
#36 | 2018-04-19 ✅ Patent 10,933,047 granted on 2021-03-02Stabilized cabazitaxel formulations
#37 | 2018-04-05 ✅ Patent 10,220,072 granted on 2019-03-05Mesalamine for the treatment of cancer
#38 | 2018-03-29 ✅ Patent 10,500,185 granted on 2019-12-10Stabilized cabazitaxel formulations
#39 | 2018-03-15Methods for Making Serotonin Reuptake Inhibitors
#40 | 2018-01-25 ✅ Patent 10,039,752 granted on 2018-08-07Methazolamide for the treatment of cancer
#41 | 2018-01-25 ✅ Patent 10,391,080 granted on 2019-08-27Ketorolac for the treatment of cancer
#42 | 2018-01-25 ✅ Patent 10,098,860 granted on 2018-10-16Bezafibrate for the treatment of cancer
#43 | 2018-01-04 ✅ Patent 9,867,865 granted on 2018-01-16Mesalamine for the treatment of cancer
#44 | 2017-12-14 ✅ Patent 10,300,044 granted on 2019-05-28Polymorphic forms of methyl((1S)-1-(((2S)-2-(5-(4′-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate and salts thereof
#45 | 2017-11-23 ✅ Patent 11,077,124 granted on 2021-08-03Pharmaceutical compositions
#46 | 2017-08-24 ✅ Patent 10,208,058 granted on 2019-02-19Process for the preparation of macrocyclic ketone analogs of halichondrin B or pharmaceutically acceptable salts and intermediates thereof
#47 | 2017-07-20 ✅ Patent 9,763,901 granted on 2017-09-19Treatment of hepatitis C using histone deacetylase inhibitors
#48 | 2017-06-15 ✅ Patent 10,149,848 granted on 2018-12-11Method for the treatment of bladder cancer
#49 | 2017-06-08 ✅ Patent 10,022,377 granted on 2018-07-17Method of treating hypertension
#50 | 2017-06-08 ✅ Patent 10,071,062 granted on 2018-09-11Methods for the treatment of hepatitis C
#51 | 2017-05-04 ✅ Patent 9,913,853 granted on 2018-03-13Stabilized liquid fosaprepitant formulations
#52 | 2017-05-04Pharmaceutical Composition Comprising a Beta-2-Agonist and Anticholinergic Agent
#53 | 2017-05-04 ✅ Patent 10,188,626 granted on 2019-01-29Stabilized cabazitaxel formulations
#54 | 2017-04-27 ✅ Patent 10,188,636 granted on 2019-01-29Betahistine for the treatment of neurodegenerative diseases
#55 | 2017-02-09 ✅ Patent 9,901,585 granted on 2018-02-27Combination of azelastine and fluticasone for nasal administration
#56 | 2017-02-02Pharmaceutical Composition
#57 | 2016-12-29 ✅ Patent 9,877,953 granted on 2018-01-30Rifaximin
#58 | 2016-05-05 ✅ Patent 9,676,803 granted on 2017-06-13Efficient process for separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine
#59 | 2016-05-05Low Dose Pharmaceutical Composition
#60 | 2016-03-17 ✅ Patent 10,023,611 granted on 2018-07-17Process for the preparation of bortezomib mannitol ester
#61 | 2016-01-07 ✅ Patent 9,890,121 granted on 2018-02-13Process for preparing atazanavir sulphate
#62 | 2015-12-17Pemetrexed Complexes and Pharmaceutical Compositions Containing Pemetrexed Complexes
#63 | 2015-10-15 ✅ Patent 9,227,990 granted on 2016-01-05Antiviral phosphonate analogues and process for preparation thereof
#64 | 2015-09-10Pharmaceutical Composition
#65 | 2015-09-03 ✅ Patent 9,505,787 granted on 2016-11-29Process for preparing of bortezomib
#66 | 2015-09-03FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING DEFERASIROX AND DEFERIPRONE
#67 | 2015-08-20 ✅ Patent 10,004,721 granted on 2018-06-26Pharmaceutical antiretroviral composition
#68 | 2015-07-16 ✅ Patent 9,233,967 granted on 2016-01-12Process for the preparation of sitagliptin and intermediate compounds
#69 | 2015-07-16Topical Foam Composition
#70 | 2015-07-09 ✅ Patent 9,259,428 granted on 2016-02-16Combination of azelastine and fluticasone for nasal administration
#71 | 2015-04-09 ✅ Patent 9,446,054 granted on 2016-09-20Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids
#72 | 2015-03-19 ✅ Patent 9,402,854 granted on 2016-08-02Pharmaceutical composition
#73 | 2015-03-19Pharmaceutical Compositions Comprising Ebastine and Fluticasone
#74 | 2015-02-12 ✅ Patent 9,993,561 granted on 2018-06-12Rifaximin complexes
#75 | 2015-02-05 ✅ Patent 9,993,560 granted on 2018-06-12Rifaximin complexes
#76 | 2015-02-05Low Dose Pharmaceutical Composition Comprising Zanamivir
#77 | 2014-10-16Pharmaceutical Composition
#78 | 2014-09-11Process for the Preparation of an Endothelin Receptor Antagonist
#79 | 2014-07-10Process for Preparation of Erlotinib and its Pharmaceutically Acceptable Salts
#80 | 2014-06-05 ✅ Patent 9,713,685 granted on 2017-07-25Dose counter
#81 | 2014-05-29Pharmaceutical Composition Comprising Deferasirox
#82 | 2014-05-29 ✅ Patent 10,179,139 granted on 2019-01-15Pharmaceutical composition
#83 | 2014-05-08Rifaximin
#84 | 2013-12-12Pharmaceutical Compositions
#85 | 2013-11-28Topical Foam Composition
#86 | 2013-11-28Pharmaceutical Composition
#87 | 2013-10-17Pharmaceutical Compositions
#88 | 2013-09-26Low Dose Pharmaceutical Composition Comprising Zanamivir
#89 | 2013-08-08Topical Foam Composition
#90 | 2013-06-27 ✅ Patent 9,150,499 granted on 2015-10-06Process for the preparation of nateglinide
#91 | 2013-06-27Pharmaceutical Aerosol Composition
#92 | 2013-06-13 ✅ Patent 8,912,337 granted on 2014-12-16Salts and polymorphs of dexrabeprazole
#93 | 2013-06-13Process for the Preparation of Esomeprazole Magnesium Dihydrate
#94 | 2013-03-28Pharmaceutical Combinations
#95 | 2013-01-31 ✅ Patent 8,937,057 granted on 2015-01-20Combination of azelastine and mometasone for nasal administration
#96 | 2013-01-31 ✅ Patent 8,933,060 granted on 2015-01-13Combination of azelastine and ciclesonide for nasal administration
#97 | 2013-01-31Darunavir Polymorph and Process for Preparation Thereof
#98 | 2012-09-13 ✅ Patent 9,018,376 granted on 2015-04-28Polymorphic forms of manidipine
#99 | 2012-08-30 ✅ Patent 8,735,589 granted on 2014-05-27Process for the synthesis of naratriptan
#100 | 2012-06-28 ✅ Patent 9,000,158 granted on 2015-04-07Process for preparing levosimendan and intermediates for use in the process
Also check out CIPLA LIMITED's (Mumbai, India) applicant profile with 67 patent applications submitted.
7351 ⎘